DEPARTMENTS | DIRECTORY | ADVANCED SEARCH | SCHOOL HOME
School Home NYU School of Medicine

irb
 Today is Friday, August 29th 2008
 
Guidance Documents
Decision Charts -
Human Subject Regulations Decision Charts
NYU SoM IRB Guidelines for Writing a Research Protocol
Guidance of Required Elements of a Protocol
Guidance on Determining Human Subjects Research
Guidance on Submitting a New Application
Guidance on Using an FDA Regulated Product
Guidance for the Investigator as a Sponsor
Guidance for Data Monitoring Plans
Guidance for Emergency Use of an IND
Guidance for Emergency Use of an IND-IDE
Guidelines for Research in Pregnant Women, Human Fetuses and Neonates
Guidance on Research with Prisoners
Guidelines for Involving Children in Research
Guidance for Cognitively Impaired
Guidance for Students and Employees in Research
Guidelines for Recruitment of Research Subjects
Guidelines for Advertisements for Research Subjects
Guidance on Genetic Research
Guidelines on Protocol Development for Genetic Research
Guidance on the Consent Process and Documentation
Guidelines of Requests for Waiver of Consent
Guidance on Assent of A Minor
Guidance for Non-English Speaking Subjects
Guidance on Verbal Consent
Guidance on Waiver of Parental Permission
Guidelines for Amending a Protocol
Guidance on Continuing Review and Final Closures
Essential Documents
Guidelines to Investigator Responsibilities
Letter for Sponsors - Reportable Events Policy
Guidance for Reportable Events and Reporting Unanticipated Problems
Reviews Preparatory to Research

Research Data Compilations

How many copies do I submit?
 

Reviews Preparatory to Research

Download this page in PDF | MS Word


1). All human subjects research requires IRB review to determine either a) exempt status or b) need for further review.


As a matter of IRB policy only individuals who have access to PHI as part of their care or administrative duty to patients may access their PHI without prior IRB Privacy Board review and approval.


2). Reviews preparatory to research that are permitted under HIPAA may or may not be human subjects research depending on the investigation being conducted.


a.) Only those reviews of a database by an individual entitled to access that database intended to enumerate an available data set without reviewing PHI and for which no PHI is recorded do not require review. For example: medical records may be queried for information such as: In the year XXXX how many patients had a discharge diagnosis of [indicate disease/diagnosis]. IRB Privacy Board Review is required for all other uses of PHI as indicated.


b.) If the research involves a de-identified data set, defined as removing the following identifiers:


Names
Geographic info. (city, state, and zip)
Elements of Dates (except years)
Telephone #s
Fax #s
E-mail address
Social Security#
Medical Record, prescription #s
Health Plan Beneficiary #s
Account #s
Certificate /License #s
VIN and Serial #s, license plate #s.
Device identifiers, serial #s
Web URLs
IP address #s
Biometric identifiers (finger prints)
Full face, comparable photo images
Unique identifying #s


, then a de-identified data set certification form must be completed submitted for administrative review and certified prior to accessing the data set. This activity also requires an IRB determined exemption from review, therefore you will need to submit the Application for Exemption from Review Form in addition to the HIPAA De-identification Certification Form.


c.) If the research involves a limited data set, defined as removing the following 15 identifiers:


Names
Postal address info. (if other than city, state and zip)
Telephone and fax #s
Email addresses
Social Security #s
Medical record, prescription numbers
Health plan beneficiary #s
Account #s
Certificate/license #s
Vin and serial #s, license plate #s
Device identifiers, serial #s
Web URLs
IP address #s
Biometric identifiers (finger prints)
Full face, comparable photo images

The following forms are required:
Information on the Creation of a Limited Data Set
Data Use Agreement
Human Subjects Application (Application for New Protocol)
Consent and Authorization or properly justified request for a waiver or modification of consent and/or authorization.


IRB Privacy Board review and approval is required prior to initiating this research. Investigators are not authorized to contact potential research subjects identified in reviews preparatory to research unless they are directly responsible for care of the potential subject and entitled to PHI as a result of that duty.

Reminder NYUSOM Recruitment Policy:

IRB Privacy Board review and approval is required prior to initiating this research. Investigators are not authorized to contact potential research subjects identified in reviews preparatory to research unless they are directly responsible for care of the potential subject and entitled to PHI as a result of that duty.

If the investigator intends to recruit potential subjects with which the investigator has no professional relationship, the following procedures are prescribed:

  • Obtain permission of the patient’s physician other healthcare provider known to the patient, and
  • Provide IRB-approved study information (brief) to the patient’s physician or other healthcare provider known to the patient, and
  • Healthcare Provider/physician or their agent provides the patient with an introduction to the study and the name of the investigator (staff member), to contact if the prospective subject is interested in the research.


Investigator’s who have previously obtained full consent and authorization to contact a research subject as a result of a previously approved research project, may contact his or her former research subjects provided that the subject agreed to be contacted for information on future research conducted by the same principal investigator or co-investigator (s). The following standard language can be used to include in current approved consent documents to obtain the subjects permission to be contacted by the principal investigator or co-investigator for future research conducted by original principal investigator or co-investigators:


I authorize the principal investigator and his or her co-investigators to contact me about future research on (specify type of research) within the (insert department, division, or center) provided that this future research is approved by the original IRB of record and that the principal investigator and co-investigator are affiliated with the research protocol.


If I agree, then someone from Dr. (insert)’s research staff might contact me in the future and he or she will tell me about a research study. At that time, I can decide whether or not I am interested in participating [am interested in having my child participate] in a particular study. I will then have the opportunity to contact the researcher to schedule an appointment to be fully informed about the research project.


____ I agree to be contacted by the Principal Investigator or Co-Investigators of the research study titled: (insert title of study)
____ I do not want to be contacted by the Principal Investigator or Co-Investigator of the research study titled:

__________________________________________________________________
Signature Date


Your permission to allow us to contact you about future research would be greatly appreciated, but it is completely voluntary. If you choose not to allow us to contact you, it will not affect your care [or your child’s care] at any of the NYUSM facilities. Please understand that giving your permission to do this is only for the purpose of helping us identify subjects who may qualify for one of our future research studies. It does not mean that you [your child] must join in any study.

 



 


 

IRB Resources
HRPP Accreditation Tutorial
IRB CITI Tutorials
Decision Charts -
Human Subject Regulations Decision Charts
IRB Newsletter
IRB Course Calendar
Policies and Procedures
HELP Downloading Forms
Lay Glossary
Useful Web Links
Sponsored Programs Administration (SPA)
Office of Clinical Trials (OCT)
Email a Suggestion or Comment to the IRB
Contact the IRB
GCRC Web Page
Instructions for Research Conducted at Bellevue
Printer-Friendly Version
Email this to a friend


Dept. Home | FAQs | IRB Forms | HIPAA Forms | Other Forms | Consent Templates | Info Sheets | Tool Kit | Schedule | Categories of Review | Policies | Glossary | Helpful Web Links | FWA | Contact